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Aim: The primary aim of this investigation into the correlation between prosthetic breast 
reconstruction, antibiotic prophylaxis and surgical drains was to determine whether the 
short-term prophylaxis recommended in the current guidelines is in fact able to sterilize 
the peri-prosthetic pocket in patients undergoing prosthetic breast reconstruction via tissue 
expansion, permanent implant placement, or Becker implants, as well as augmentation to 
correct symmetry. Methods: A total of 96 women who had undergone prosthetic breast 
reconstruction surgery were considered. Patients were recruited from the Plastic Surgery 
Clinic, Gemona, and the Surgery Clinic, Udine, both affiliated with the Udine “Santa Maria 
della Misericordia” University Hospital between May 2013 and May 2014. All patients 
were administered the recommended short-term antibiotic prophylaxis, i.e. 2 g cephazolin 
(plus 1 g eventually given after 3.5 h of surgery) 30 min before surgery. Records pertaining 
to each patient were kept in a specific study chart. Results: Samples of peri-prosthetic 
drainage fluid were taken from 92.5% of the recipients of breast reconstruction/implant 
surgery. Only 2.3% of the samples analyzed were found to be positive for microbial strains. 
Conclusion: The results of this preliminary study are encouraging, demonstrating that the 
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INTRODUCTION
The guidelines in use at the Udine S. Maria della 
Misericordia University hospital, which conform to the 
recommendations published by the Italian National 
Guidelines System (SNLG) and adopted by the Friuli-
Venezia-Giulia Regional Health Authority, recommend 
short-term pre-operative antibiotic prophylaxis via 2 g of 
cephazolin for breast implant patients, plus 1 g for 
operations scheduled to last more than 3.5 h. The 
guidelines specify that antibiotic prophylaxis must be 
administered immediately before (in this case 30 min) 
surgery, and be limited to the peri-operative period.
The literature indirectly confirms the efficacy of the 
short-term prophylaxis proposed in the guidelines, 
and published evidence supporting the superiority of 
prolonged prophylaxis is notably absent.[1-3] Hence, 
based on the current evidence, extending prophylaxis 
to cover the first 24 h of the post-operative period can 
only be justified if there are major risk factors for post-
surgical infection, and the reasons behind any decision 
to prolong prophylaxis beyond the recommended limit 
must be noted in the patient’s medical records.[4,5]
Although we can assume that most, if not all, specialists 
in the sector adhere to such guidelines, the duration of 
antibiotic prophylaxis is nonetheless often the object of 
much discussion. Aside from the fear of peri-prosthetic 
infections, major concerns are also raised by the 
sequelae of infections, in particular implant loss, delays 
in neo-adjuvant therapy administration, unsatisfactory 
aesthetic outcomes and the need for further corrective 
surgery, not to mention potential medico-legal issues.[6,7]
Indeed, peri-prosthetic pocket infections tend to 
develop subclinically, leading to capsular contracture 
and other post-implant complications without overt 
signs or symptoms. However, peri-prosthetic discharge 
may represent an effective marker of even subclinical 
peri-prosthetic infection, and can be easily obtained 
from post-operative surgical drains. 
Hence, in order to make a contribution, however minor, 
to this debate, the authors conducted a microbiological 
analysis of the peri-prosthetic discharge of breasts 
treated at Udine University Hospital. The aim was to 
establish objectively whether the short-term prophylaxis 
recommended in the guidelines is able to sterilize the 
peri-prosthetic pocket.
METHODS
Patients were recruited from the Plastic Surgery Clinic, 
Gemona, and the Surgery Clinic, Udine, both affiliated 
with the Udine “Santa Maria della Misericordia” 
University Hospital between May 2013 and May 2014. 
All study patients signed informed consent and gave 
their permission for publication of their pictures and 
samples analysis for research purpose; 86 patients 
(92.5%) of the 96 considered.
Inclusion criteria consisted of all women undergoing 
breast implant surgery, comprising: (1) post-
mastectomy breast reconstruction via tissue expander/
implant or Becker expander; (2) expander/implant 
replacement surgery; and (3) breast augmentation to 
correct asymmetry.
The patient sample also included 3 cases of corrective 
surgery secondary to complications arising in the 
post-operative period, in particular: (1) 1 implant 
replacement with contralateral mastopexy following 
Becker expander rupture; (2) 1 implant replacement 
with latissimus dorsi myocutaneous flap following 
implant exposure; and (3) 1 latissimus dorsi 
myocutaneous flap reconstruction implant with breast 
implant and contralateral mastopexy following breast 
cancer relapse. 
A total of 96 women who had undergone prosthetic 
breast reconstruction surgery were considered. In 50 
patients, reconstruction was performed immediately 
after mastectomy (modified radical, nipple-sparing 
or skin-sparing) following a diagnosis of breast 
cancer. Surgery was performed to fit either a tissue 
expander or a permanent implant, accompanied or 
not by contralateral mastopexy. In an additional 12 
patients, deferred post-mastectomy reconstruction 
via expander or permanent implant positioning, with 
or without latissimus dorsi flap reconstruction and/or 
contralateral mastopexy, was performed. In another 
group of 31 patients, expanders were replaced with 
permanent implants, with or without contralateral 
mastopexy and/or lipofilling. The remaining three 
patients underwent corrective surgery secondary 
to post-implant complications, specifically implant 
rupture, implant exposure, and breast cancer relapse, 
respectively. 
All patients received the recommended short-term 
antibiotic prophylaxis, i.e. 2 g cephazolin (plus 1 g 
eventually given after 3.5 h of surgery) 30 min before 
surgery.
Records pertaining to each patient were kept in a 
specific study chart, the first part comprising the 
patient’s personal information, diagnosis, lesion site, 
and type of surgery received. The second part of the 
study chart was used to compile data pertaining to 
the patient’s “unnecessary” habits (smoking, drinking, 
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not having a good diet, etc.), co-morbidities, and any 
medication or complementary treatment received or 
ongoing, while the third part was used to record the 
microbiological tests carried out, the results thereof, 
any microbial strain detected, and any signs of overt 
infection.
RESULTS
Samples of peri-prosthetic drainage fluid were 
taken from 86 (92.5%) of the 96 recipients of breast 
reconstruction/implant surgery; the remaining 7.5% 
of patients did not adhere to the study. In this patient 
population the recommended short-term antibiotic 
prophylaxis was performed and the fluid collected was 
analyzed for microbiological contamination. 
Samples were taken under sterile conditions by 
aspirating the peri-prosthetic fluid directly from the 
drain using a syringe, and transferring to sterile cotton 
swabs [Figures 1 and 2]. Samples were taken on the 
third day after surgery and upon drain removal (overall 
two times), and sent directly to the lab for testing.
Only 3 out of the 86 samples analyzed (2.3%) 
were found to be positive for microbial strains, 
specifically Pseudomonas aeruginosa [Figures 3-5] 
and Propionibacterium acnes, respectively. In 1 
case, a peri-prosthetic accumulation formed in the 
post-operative period was found to be positive for 
Staphylococcus aureus, but the drainage fluid taken 
from the same patient tested negative. In regards to the 
clinical and therapeutic characteristics of the patients 
who tested positive, the 55-year-old S. aureus patient, 
after mastectomy and expander placement, developed 
a fever, increased breast volume, and collection 
of pus, and the expander was therefore removed. 
The 45-year-old patient whose drainage fluid tested 
positive for Pseudomonas aeruginosa experienced 
Figure 1: Aspirating fluid from the surgical drain
Figure 2: Preparing samples for microbiological testing
Figure 3: Evident signs of infection in the mastectomy/expander 
patient who tested positive for Staphylococcus aureus
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gradual loss of the apical portion of the skin paddle, 
originating at the medial apex, and consequent implant 
exposure following mastectomy and latissimus dorsi 
myocutaneous flap reconstruction. It is likely that 
the bacterial contamination of the peri-prosthetic 
environment was due to this exposure. Clinically, the 
patient demonstrated high inflammation indices and 
an accumulation of peri-prosthetic fluid, which was 
drained from the area of tissue loss.
In contrast, the 52-year-old mastectomy and implant 
reconstruction patient who tested positive for 
Propionibacterium acnes developed no clinical signs 
of infection, and completed the tissue expansion cycle 
with success. As no clinical signs of infection appeared 
during this cycle, the patient was not medicated, and the 
positive result was tentatively ascribed to contamination 
of the sample, pending further monitoring.
DISCUSSION
For each patient, including the three who tested 
positive for contamination, the variables associated 
in the literature with a greater risk of peri-prosthetic 
infection were analyzed. The first of these variables 
was age. The mean age of the 86 patients studied was 
53 years. Forty-four out of 96 (45%), i.e. the majority, 
fell into the range of 45 to 55 years of age. Ten (20.8%) 
were in the age range 44 to 35 years, 18 (18.7%) were 
between 65 and 74 years of age, and the remaining 
14 (14.5%) were aged between 55 and 64 years. 
There is no statistically significant correlation between 
advanced patient age and the risk of contracting a 
surgical site infection (SSI) in the literature, as the 
majority of studies show no statistically significant 
relationship between these 2 variables.[2,8] In fact, 
rather than age, authors are more inclined to consider 
the presence of co-morbidities and the overall physical 
condition of the patient prior to surgery. Nevertheless, 
all three patients in the current study who had samples 
positive for microbial strains were of an intermediate 
age, with the patient infected by Staphylococcus 
aureus being 55 years old, the patient infected by 
Pseudomonas aeruginosa 45 years, and the patient 
infected by Propionibacterium acnes 52 years. The 
fact that these patients were not elderly confirms the 
widespread opinion in the literature that the risk of SSI 
onset is not conditioned by advanced age. 
The second variable studied was smoking. Of the 86 
patients, 14 (16.2%) were smokers, smoking a mean 
of 10 cigarettes a day, and had been smoking for an 
average of 15 years. The literature contains many 
studies that demonstrate a statistically significant 
correlation between smoking and SSI risk, and the 
majority of authors contend that there is a statistically 
significant relationship between these 2 variables.[9,10] 
However, these studies do suffer from a common 
limitation, namely that it is difficult to define terms like 
“regular” and “active” smoking statistically. In order to 
obtain statistically valid data on this variable, it would 
be necessary to adopt standardized measures of 
smoking history and find suitable controls to eliminate 
any bias.
Wound healing is dependent on the local blood 
supply, and smoking induces a state of chronic 
Figure 4: Latissimus dorsi myocutaneous flap failure and implant exposure in a patient who tested positive for Pseudomonas aeruginosa
Figure 5: Patient positive for Propionibacterium acnes without 
clinical signs of infection
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vasoconstriction, reducing blood vessel gauge and 
thereby reducing the flow of blood. Furthermore, the 
appearance of the scar is also adversely affected by 
smoking, and it is therefore strongly suggested that 
patients refrain from smoking in the 2-3 weeks before 
and after the operation. In the current study, however, 
none of the 3 women who tested positive admitted to 
smoking, and it is therefore impossible to confirm the 
literature findings in this sample.
The third variable considered in this study was the 
presence of co-morbidities. The majority of the 86 
patients studied (70; 81.4%) were not found to be 
affected by other pathologies. Only 10 patients 
(11.6%) had metabolic issues or autoimmune disease; 
infectious diseases were not present. There was no 
comorbidity data available for 5 cases. 
There are many studies in the literature that 
demonstrate a statistically significant correlation 
between the presence of co-morbidities in general 
and an increased risk of contracting an SSI.[11-13] The 
National Nosocomial Infections Surveillance System 
considers three key variables to be independently 
associated with the risk of SSI, namely: (1) a wound 
infected or contaminated surgically; (2) the duration 
of the operation; and (3) an American Society of 
Anesthesiologists (ASA) Physical Status Classification 
score greater than 2. Olsen et al.[14] also demonstrated 
that an ASA score of 2 or 3 is associated with a 
statistically significant risk of developing an SSI. 
Regarding metabolic function disorders, many 
researchers have set out to find a possible link 
between diabetes mellitus, for example, and the risk 
of peri-prosthetic infection. However, secondary to 
contrasting findings reported in the literature, this 
topic remains controversial.[8,14] As none of the three 
patients who tested positive in our study suffered from 
any metabolic diseases, the authors can add little to 
this debate.
There is no data in the literature suggesting that 
autoimmune diseases may represent a possible risk 
factor for SSIs. Nevertheless, the potential role of the 
drugs used to treat these conditions, e.g. steroids, 
cytostatics and immunosuppressors (azathioprine, 
cyclosporine), have been widely studied. The 
findings of several of these studies[15-17] appear to 
suggest that patients treated pre-operatively with 
immunosuppressant drugs or steroids do in fact run 
a greater risk of SSIs. However, none of the three 
patients who tested positive in the current study 
had any concomitant diseases, and therefore no 
conclusions can be drawn in this regard.
The fourth variable analyzed was the presence of 
any complementary treatments administered prior to 
surgery, and their various combinations (chemotherapy, 
radiotherapy, hormone therapy). The majority (72; 
83.7%) of the 86 patients in our sample had not 
received any complementary treatment, while the 
remaining 14 had a fairly uniform distribution in terms 
of the combination of possible treatment combinations. 
Regarding radiotherapy (RT), the literature contains 
many studies which demonstrate a significant correlation 
between preoperative RT and the development of an 
SSI. Indeed, RT can provoke skin damage by the 
occlusion or damage of the microvascular system and 
chromosomal damage to the fibroblasts, inhibiting stem 
cell replication, angiogenesis, and collagen production. 
This manifests during the final phases of treatment 
as hyperemia and inflammation of the skin. Although 
this is a frequent occurrence, it is easily remedied via 
suitable topical treatment, and seldom necessitates 
the interruption of treatment. Nonetheless, connective 
tissue may also be damaged, and in the later stages 
of RT, areas of sclerosis, fibrosis, and hypertrophy of 
the pectoral muscle may occur. By provoking tissue 
fibrosis and microvascular damage, therefore, RT 
may delay wound healing, and can be associated with 
dehiscence, necrosis and infection. Moreover, when RT 
precedes reconstructive surgery, post-actinic damage 
may complicate the tissue expansion necessary to 
house the implant, as well as increase the risk of peri-
prosthetic fibrosis and capsular contracture.[8,14]
The role of preoperative chemotherapy (CT) as a 
potential peri-prosthetic infection risk factor has also 
been widely studied. Although contrasting results have 
been reported, CT is known to cause myelosuppression 
and neutropenia, and thereby potentially increase the 
risk of infection.[8,16] In the current study, however, none 
of the 3 patients whose samples tested positive for 
microbial contamination had previously received CT. In 
fact, of these 3 cases, only 1 (infected by Pseudomonas 
aeruginosa) had undergone complementary treatment 
consisting of RT plus hormone therapy. Although 
the size of the sample does not enable meaningful 
statistical analysis, the influence of RT cannot be ruled 
out in this case. 
The fifth variable considered was the use of post-
surgical wound drains. Indeed, the drains themselves 
may represent a risk factor for infection by promoting 
biofilm formation on the surface of the device, which 
may in turn promote the transfer of bacteria into the 
wound. It is also possible to contaminate the lower 
end of the drain during disconnection and emptying, 
potentially causing intra-luminal infection and 
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contamination of the wound.[15,18,19] Hence, although 
the drain performs an indispensable function, namely 
to eliminate accumulated serum from the wound site 
and thereby deprive endogenous pathogens of an 
excellent medium for proliferation, it can provide a 
route through which such pathogens can enter the 
body.[20-24]
As mentioned previously, the regional guidelines 
for antibiotic prophylaxis (AP) dictate the use of 2 g 
cephazolin (plus 1 g in operations lasting longer than 
3.5 h) solely before surgery. Cephazolin, the first choice 
antibiotic, is a cephalosporin that protects against a 
wide range of both gram-positive (staphylococcus 
strains, including aureus; coagulase-negative 
staphylococci, with the exception of methycillin-
resistant strains; beta-haemolitic streptococcus 
groups A and B) and gram-negative (E. coli and 
Klebsiella) bacteria. Cephalosporins are generally 
well-tolerated and inexpensive drugs with time-
dependent pharmacokinetics and a half-life of roughly 
2 h. They are considered high protein bonding (85%), 
and provide excellent tissue distribution. Cephazolin, 
in particular, is one of the preferred options for clean 
surgery.
In cases of cephalosporin allergy, vancomycin or 
clindamycin are other viable options. Other drugs, 
such as ampicillin, amoxicillin, piperacillin, ampicillin/
sulbactam, and amoxicillin/clavulanic acid, are also 
widely used for surgical applications, and are very 
efficacious against enterococcus strains, albeit no 
more so than the cephalosporins in AP.
The study charts showed that all 86 were administered 
2 g of cephazolin intravenously, 30 min before skin 
incision, with an additional 1 g in cases lasting longer 
than 3.5 h. With this treatment, as already stated, 3 
out of the 86 showed contaminated drainage secretion 
and 1 peri prosthetic infection but sterile drain. 
The study charts confirmed adherence to the duration 
of AP suggested by both the literature and regional 
guidelines. Indeed, there is no statistical proof that long-
term AP (for example until the time of drain removal) 
is any more efficacious at preventing SSIs.[4] On the 
contrary, there are various reports that extending AP to 
cover tubes, drains and catheters is either useless[1,2,8] 
or inadvisable.[25,26] 
Despite this evidence, it has been reported that many 
hospitals, both in Italy and abroad, routinely use long-
term AP in surgical cases. Perrotti et al.,[6] for example, 
state that over 50% of the plastic surgeons interviewed 
administer AP well beyond the operating time, and as 
many as 61% until drain removal. Although this behavior 
is not very judicious, it is understandable. Indeed, 
should a surgery patient fall prey to an SSI, there are 
many legal questions to consider, not to mention the 
clinical and financial consequences of their sequelae, 
which may include implant loss, delay in neo-adjuvant 
therapy, unsatisfactory or unsightly outcomes, and, as 
a consequence, prolonged hospital stays and even 
revision surgery. This represents a strong incentive for 
surgeons to administer postoperative AP, especially 
in patients with drains, in the hope that prolonging 
the course of AP will reduce the risk of SSI. The 
practice is even more common in immediate prosthetic 
reconstruction patients, with the fear of infection-
related implant loss being the driving concern.[27,28]
However, the unrestrained use of antibiotics, perhaps 
fueled by the lack of prospective studies in the 
literature, has led to the development of methicillin-
resistant colonies of Staphylococcus epidermidis, and 
to an increase in the incidence of colitis secondary 
to Clostridium difficilis, in addition to side effects 
and secondary infections. Furthermore, antibiotics 
administered after wound closure seem to have no 
prophylactic effect on bacterial contamination during 
the surgery itself.[29,30]
Having administered short-term AP as per the 
recommended guidelines, 2 (2.5%) out of the 80 patients 
drain secretion samples analyzed were found to be 
positive for microbial strains, specifically Pseudomonas 
aeruginosa in 1 case and Propionibacterium acnes 
in the other. The patient whose drain was found to 
be positive for Pseudomonas aeruginosa developed 
progressive loss of the apical portion of the skin paddle, 
originating at the medial apex, and consequent implant 
exposure in the postoperative period. This makes 
it likely that the route of the bacterial contamination 
was, in fact, the exposed implant. In contrast, the 
patient whose drainage secretion tested positive for 
Propionibacterium acnes developed no clinical signs 
of infection, and completed the weekly expansion cycle 
with no complications. 
In a further patient, a positive result for Staphylococcus 
aureus was detected in a peri-prosthetic accumulation 
formed in the post-operative period, but the fluid taken 
from the drain of the same patient was found to be 
negative.
As contaminated drainage samples were found in only 
2 out of the 86 patients, one conceivably attributable 
to implant exposure, this study appears to confirm 
the validity of the current guidelines regarding short-
term AP. Nevertheless, there are certain limitations 
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to declare. First, as the operations were performed 
in more than one hospital, rigid standardization of 
the study protocol was not possible. Although the 
medical and nursing staff had been trained to adhere 
to the rules of the study, several (16) cases had to be 
excluded due to procedural inaccuracies. The major 
limitation of the study, however, was the small sample 
size, which prevents the conclusions from achieving 
statistical significance. 
Nevertheless, patients have continued to be added 
to the study group, with a view to increasing the data 
available and addressing certain secondary objectives. 
Specifically, the authors wish to evaluate, via 
microbiological analysis of the peri-prosthetic pocket 
during revision surgery, whether subclinical colonization 
persists upon implant replacement, and whether or not 
bacterial colonization leads to a greater incidence of 
capsular contracture. It will also be interesting to follow 
the progress of the patient whose peri-prosthetic fluid 
tested positive for Propionibacterium acnes upon 
drain removal, despite an absence of signs of clinical 
infection. In particular, the patient will be monitored 
for any sign of capsular contracture, which would lend 
weight to the literature hypothesis that peri-prosthetic 
infection is an important risk factor for this event in the 
long term. Should contracture indeed occur, it will also 
be interesting to note whether the microbial species 
isolated from the capsule is the same as that present 
in the drain fluid.
Despite the above-mentioned limitations, the results of 
this preliminary study are encouraging, demonstrating 
that the guidelines regarding short-term AP are indeed 
effective. However, it remains to be demonstrated 
that not prolonging prophylaxis does not statistically 
increase the risk of surgical failure, and does not 
therefore expose either the patient or surgeon to the 
burden of complications, whether major or minor. 
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